UK-Backed Startup Potential Sciences Launches to Build AI Drug Discovery Using Simulated Data
Launched November 5, 2026, the UK startup has raised tens of millions of dollars from SovAI and Twin Path Ventures. Its physics-based simulations will generate biochemical datasets to train models that predict drug–protein interactions and help compounds fail fast.